相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study
V. Smith et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies
J. H. W. Distler et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome A Randomized, Double-Blind, Placebo-Controlled Trial
J. M. Meijer et al.
ARTHRITIS AND RHEUMATISM (2010)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study
Dimitrios Daoussis et al.
RHEUMATOLOGY (2010)
Basiliximab or Antithymocyte Globulin for Induction Therapy in Kidney Transplantation: A Meta-analysis
Y. Liu et al.
TRANSPLANTATION PROCEEDINGS (2010)
Imatinib in the Treatment of Nephrogenic Systemic Fibrosis
Sindhu Chandran et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Proliferation Signal Inhibitors for the Treatment of Refractory Autoimmune Rheumatic Diseases A New Therapeutic Option
Kam Hon Yoon
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Rachel B. Jones et al.
ARTHRITIS AND RHEUMATISM (2009)
Reply to letter by Gallo and Petrek commenting on interleukin-1 receptor antagonist and interleukin-6 polymorphisms and post-total hip arthroplasty osteolysis
A. Gordon et al.
ARTHRITIS AND RHEUMATISM (2009)
Treatment With Imatinib Prevents Fibrosis in Different Preclinical Models of Systemic Sclerosis and Induces Regression of Established Fibrosis
Alfiva Akhmetshina et al.
ARTHRITIS AND RHEUMATISM (2009)
Rapamycin Versus Methotrexate in Early Diffuse Systemic Sclerosis Results From a Randomized, Single-Blind Pilot Study
Tien-I Karleen Su et al.
ARTHRITIS AND RHEUMATISM (2009)
Survival in Pulmonary Hypertension Associated With the Scleroderma Spectrum of Diseases Impact of Interstitial Lung Disease
Stephen C. Mathai et al.
ARTHRITIS AND RHEUMATISM (2009)
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Belimumab in Patients With Active Systemic Lupus Erythematosus
Daniel J. Wallace et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
B Cell Depletion With Rituximab in Patients With Diffuse Cutaneous Systemic Sclerosis
Robert Lafyatis et al.
ARTHRITIS AND RHEUMATISM (2009)
Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology
H. -P. Hartung et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Intravenous immunoglobulins - understanding properties and mechanisms
A. Durandy et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Significant improvement of right ventricular function by imatinib mesylate in scleroderma-associated pulmonary arterial hypertension
Henrik ten Freyhaus et al.
CLINICAL RESEARCH IN CARDIOLOGY (2009)
Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice
Matthew J. Parker et al.
DIABETES (2009)
Extracorporeal photoimmunotherapy-photopheresis
Theresa Dani et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Everolimus-Associated Pneumonitis in 3 Heart Transplant Recipients
James Otton et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus
C. Pena-Rossi et al.
LUPUS (2009)
Transforming growth factor β as a therapeutic target in systemic sclerosis
John Varga et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
I. Sabnani et al.
RHEUMATOLOGY (2009)
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Chris T. Derk et al.
RHEUMATOLOGY (2009)
Halofuginone Inhibits TH17 Cell Differentiation by Activating the Amino Acid Starvation Response
Mark S. Sundrud et al.
SCIENCE (2009)
Polyclonal Rabbit Antithymocyte Globulin Exhibits Consistent Immunosuppressive Capabilities Beyond Cell Depletion
Gina LaCorcia et al.
TRANSPLANTATION (2009)
Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation
Stanley C. Jordan et al.
TRANSPLANTATION (2009)
High-dose cyclophosphamide without stem cell rescue in scleroderma
C. V. Tehlirian et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Stem cell transplantation: a treatment option for severe systemic sclerosis?
J. M. van Laar et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
S. Dass et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease
Juan A. Moreno-Romero et al.
ARCHIVES OF DERMATOLOGY (2008)
Is imatinib mesylate a promising drug in systemic sclerosis?
P. L. A. van Daele et al.
ARTHRITIS AND RHEUMATISM (2008)
The controversial role of tumor necrosis factor α in fibrotic diseases
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2008)
Imatinib mesylate treatment of nephrogenic systemic fibrosis
Jonathan Kay et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHD
L. Magro et al.
BONE MARROW TRANSPLANTATION (2008)
Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
Anthony J. Gerbino et al.
CHEST (2008)
The effect of imatinib (Glivec (R)) on scleroderma and normal dermal fibroblasts: A preclinical study
A. Soria et al.
DERMATOLOGY (2008)
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis
Alfiya Akhmetshina et al.
FASEB JOURNAL (2008)
Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-β-induced mouse fibrosis
Yuka Ikawa et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis
Ivan Nestorov et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Extracorporeal photopheresis for the treatment of Sezary syndrome using a novel treatment protocol
Suzanne Arulogun et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Efficacy of Rapamycin in Scleroderma: A Case Study
Levi Fried et al.
Lymphatic Research and Biology (2008)
Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice
Sing Leung Lui et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
Ana C. Zamora et al.
RESPIRATORY MEDICINE (2008)
Vascular disease in scleroderma: Mechanisms of vascular injury
Bashar Kahaleh
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Scleroderma-like fibrosing disorders
Francesco Boin et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2008)
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
Carlotta Nannini et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis
Y. Oyama et al.
BONE MARROW TRANSPLANTATION (2007)
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study
Richard A. Nash et al.
BLOOD (2007)
Advances in immunosuppressive therapy
Wendy Marder et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+functional regulatory T-cells in patients with graft-versus-host disease
Ettore Biagi et al.
TRANSPLANTATION (2007)
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study
F. Nacci et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma
H. Ihn et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis - a retrospective analysis
S. I. Nihtyanova et al.
RHEUMATOLOGY (2007)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sezary syndrome
P. Tsirigotis et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Alefacept: Its safety profile, off-label uses, and potential as part of combination therapies for psoriasis
Noah Scheinfeld
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
The role of basiliximab induction therapy in organ transplantation
Carlo B. Ramirez et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus
David Fernandez et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease
S. N. C. Liossis et al.
RHEUMATOLOGY (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
P Emery et al.
ARTHRITIS AND RHEUMATISM (2006)
A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis
O Nadashkevich et al.
CLINICAL RHEUMATOLOGY (2006)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
EM Ginzler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The patient: Emerging clinical applications of intravenous immunoglobulin
RD Harvey
PHARMACOTHERAPY (2005)
Tumor necrosis factor (TNF) α increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2
AL Theiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Autoantibodies to fibrillin-1 activate normal human fibroblasts in culture through the TGF-β pathway to recapitulate the scleroderma phenotype
XD Zhou et al.
JOURNAL OF IMMUNOLOGY (2005)
Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients
S Garrean et al.
CLINICAL TRANSPLANTATION (2005)
Tumor necrosis factor-α induces transforming growth factor-α expression in lung fibroblasts through the extracellular signal-regulated kinase pathway
DE Sullivan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin
L Buschhausen et al.
MEDIZINISCHE KLINIK (2005)
The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules
A Johnston et al.
CLINICAL IMMUNOLOGY (2005)
Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG):: An open study in 15 patients
WH Schmitt et al.
KIDNEY INTERNATIONAL (2004)
Intravenous immunoglobulin modulates cutaneous involvement and reduces skin ribrosis in systemic sclerosis: an open-label study
Y Levy et al.
ARTHRITIS AND RHEUMATISM (2004)
Autologous stem cell transplantation in the treatment of systemic sclerosis:: report from the EBMT/EULAR Registry
D Farge et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab
AJK Ostor et al.
BRITISH MEDICAL JOURNAL (2004)
Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway
D Shegogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor α
C Chizzolini et al.
ARTHRITIS AND RHEUMATISM (2003)
Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+T cells from scleroderma patients
IG Luzina et al.
ARTHRITIS AND RHEUMATISM (2003)
Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma
A Pines et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis
PQ Hu et al.
ARTHRITIS AND RHEUMATISM (2003)
High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease
RK Burt et al.
BLOOD (2003)
Fibrosis regression induced by intravenous gammaglobulin treatment
H Amital et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behcet disease
K Yamato
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice
M Blank et al.
ARTHRITIS AND RHEUMATISM (2002)
The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis
R Hubbard et al.
RHEUMATOLOGY (2002)
Halofuginone, an inhibitor of type-I collagen synthesis and skin sclerosis, blocks transforming-growth-factor-beta-mediated Smad3 activation in fibroblasts
TL McGaha et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Rapamycin: Clinical results and future opportunities
BD Kahan et al.
TRANSPLANTATION (2001)
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes
CN Ellis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis:: procedure related mortality and impact on skin disease
M Binks et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma
RJ Stratton et al.
RHEUMATOLOGY (2001)
Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma
SJ Morton et al.
RHEUMATOLOGY (2000)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
RA Clynes et al.
NATURE MEDICINE (2000)
Autologous stem cell transplantation in progressive multiple sclerosis - An interim analysis of efficacy
A Fassas et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - A preliminary report
Y Levy et al.
CLINICAL RHEUMATOLOGY (2000)
分享论文
